Inclusion of Adolescents in Preventive HIV Vaccine Trials
Authors:
- Heather B JaspanHJHeather B Jaspan
- Coleen K CunninghamCCColeen K Cunningham
- Tim J P TuckerTTTim J P Tucker
- Peter F WrightPWPeter F Wright
- Steve G SelfSSSteve G Self
- Rebecca L SheetsRSRebecca L Sheets
- Audrey S RogersARAudrey S Rogers
- Linda-Gail BekkerLBLinda-Gail Bekker
- Craig M WilsonCWCraig M Wilson
- Ann DuerrADAnn Duerr
- Judith N WasserheitJWJudith N Wasserheit
- 1 January 2008
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 47 (1) , 86-92
Abstract
The search for a safe effective HIV vaccine has been a centerpiece of HIV research for almost 2 decades. More than 60 clinical HIV vaccine trials have been conducted to date. Several promising candidate HIV vaccines are in advanced clinical development. To date, however, no trial has included adolescents, one of the most important target groups for any preventive HIV vaccine. To license a vaccine for use in this age group, efficacy data or, at a minimum, bridging safety and immunogenicity data in this population are needed. To accomplish this, several critical issues and special challenges in the development and implementation of HIV vaccine trials in adolescents must be addressed, including regulatory considerations, potential differentials in safety and immunogenicity, alternative trial design strategies, recruitment and retention challenges, community involvement models, and approaches to informed consent/assent. This article examines these issues and proposes specific next steps to facilitate the routine inclusion of this high-priority population in preventive HIV vaccine trials as early and seamlessly as possible.Keywords
This publication has 29 references indexed in Scilit:
- Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on ‘Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines’, 31 January–2 February 2006, IAVI, New York, USAAIDS, 2007
- Nested Case–Control Study of Cervical Mucosal Lesions, Ectopy, and Incident HIV Infection Among Women in Cape Town, South AfricaSexually Transmitted Diseases, 2006
- The maturing immune system: implications for development and testing HIV-1 vaccines for children and adolescentsAIDS, 2006
- Protecting Children's Rights in Social Science Research in Botswana: Some Ethical and Legal DilemmasInternational Journal of Law, Policy and The Family, 2005
- New biomedical approaches for sexually transmitted infection prevention: vaccines and microbicidesAdolescent Medicine Clinics, 2004
- Sexual Risk Behaviors Associated With Having Older Sex PartnersSexually Transmitted Diseases, 2002
- Necrotising scleritis after bare sclera excision of pterygiumBritish Journal of Ophthalmology, 2000
- The REACH Project of the Adolescent Medicine HIV/AIDS Research Network:Design, Methods, and Selected Characteristics of ParticipantsJournal of Adolescent Health, 1998
- Necrotising anterior scleritis after pterygium surgeryAustralian and New Zealand Journal of Ophthalmology, 1994
- Pterygium excision with conjunctival autografting: an effective and safe technique.British Journal of Ophthalmology, 1993